GSK vs SONO · P/E 13, $103.31B cap vs P/E 84, rev $1.44B
GlaxoSmithKline PLC ADR (GSK) versus Sonos Inc (SONO) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Sonos Inc (SONO) is a consumer electronics company listed on NASDAQ.
GSK does not have a complete income-statement cache yet.
Latest reported SONO revenue for 2025-09-27 was $1.44B. Net income was -$61.1M. SONO currently screens at market cap $1.70B and trailing P/E 84.1.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. SONO currently screens at market cap $1.70B and trailing P/E 84.1.
Not investment advice. Open the GSK and SONO stock pages for the full models.
Not investment advice.